Empowering patient-centric brain tumour research: PRIME’s Impact Report 2023
brainstrust’s PRIME (Patient Research Involvement MovEment) bridges the gap between patients and brain tumour research. As we reflect on the past year, PRIME’s 2023 Impact Report shares our achievements, challenges, […]
Little voices but big impact for brain tumour research
Whilst we’re a relatively small charity on the global stage, with our Patient Research Involvement Movement (PRIME) we make sure patients of all ages have a big voice. This weekend […]
Advancing Brain Cancer Diagnostics: Imperial’s Blood Test Offers Hope
Imperial College London researchers have developed a blood test that could offer an alternative method for the diagnosis of high-grade brain cancer. The technique has the potential to improve survival […]
Unveiling the Impact of Whole Genome Sequencing in Cancer Care
In the landscape of cancer care, hopeful initiatives like the 100,000 Genomes Project are reshaping the way we understand and treat brain tumours. As an advocate for the brain cancer […]
A Closer Look at Non-Enhancing High-Grade Gliomas
High-grade gliomas (HGG) are aggressive brain tumours with a challenging prognosis, primarily due to the challenges in controlling the diffuse invasion of tumour cells throughout the brain. One group of […]
A wonderful night of carols in Cumbernauld
A huge thanks to choir and the audience at St Mungo’s in Cumbernauld last Friday at the Annual Xmas Carol Concert. A lovely evening of festive music, singalongs and hot […]
Unravelling BRAINatomy: A Journey Towards Improved Paediatric Brain Tumour Treatments
In the realm of paediatric oncology, the BRAINatomy project aims to change outcomes for children diagnosed with a brain tumour and their families for the better, headed by the University […]
Promising Results in Recurrent Medulloblastoma with Innovative Treatment Approach
Living with recurrent medulloblastoma can be an incredibly challenging journey, particularly when facing limited treatment options. However, a recent breakthrough offers hope for patients in this difficult situation. The Medulloblastoma […]
Unraveling the Mystery: How Weekly Delta-Radiomics on MR-Linac Can Guide Glioblastoma Treatment
Glioblastoma (GBM) poses a significant challenge in treatment due to the difficulty in distinguishing true progression (TP) from pseudoprogression (PP) during chemoradiotherapy. TP signifies tumour growth with poor treatment response, […]
New brainstrust resource to help you when cancer spreads to the brain
What is secondary brain cancer? A diagnosis of brain metastasis (a single tumour) or metastases (more than one tumour) is sometimes referred to as a secondary cancer or brain secondary. […]